Title:Impaired renal function and associated risk factors in newly diagnosed HIV-infected Adults in Gulu Hospital, Northern Uganda
|
|
- Leslie Boone
- 5 years ago
- Views:
Transcription
1 Author's response to reviews Title:Impaired renal function and associated risk factors in newly diagnosed HIV-infected Adults in Gulu Hospital, Northern Uganda Authors: Pancras Odongo Ronald Wanyama James H Obol (obolh@yahoo.com) Paska Apiyo (apiyopaska2004@yahoo.co.uk) Pauline K Byakika (pbyakika@gmail.com) Version:3Date:29 December 2014 Author's response to reviews: see over
2 Author's response to reviews Title: Impaired Renal Function and its Predictors among Newly Diagnosed HIV-infected Adults in Gulu Regional Referral Hospital, Northern Uganda Authors: Pancras Odongo: Ronald Wanyama: James Henry Obol: Paska Apiyo: Pauline Byakika-Kibwika: Version: 2 Date: 28 December 2014 Author's response to reviews: see over
3 Reviewer's report Title:Impaired Renal Function and its Predictors among Newly Diagnosed HIV-infected Adults in Gulu Regional Referral Hospital, Northern Uganda Version:2Date:5 November 2014 Reviewer:Rebecca Scherzer Reviewer's report: Comments on BMC Nephrology Manuscript Number: n/a Title: Impaired Renal Function and its Predictors among Newly Diagnosed HIV infected Adults in Gulu Regional Referral Hospital, Northern Uganda General comments This manuscript prepared by Pancras Odongo and colleagues determines the rate of impaired renal function and associated factors in a cross-sectional study of 361 newly diagnosed HIV-infected men and women in northern Uganda. This is an important clinical question to address given the high prevalence of HIV infection in this resourcelimited region. HIV infection is associated with early onset of kidney disease, and yet the cost to screen all newly infected persons for kidney disease would be prohibitive. The paper is well-written, but the analyses could be strengthened and some points could be clarified: Introduction: This section is well-written, but could use a bit more context for the statement that In Uganda, HIV-associated renal disease is a growing concern. Are you seeing higher rates of ESRD or an uptick in clinical presentation of kidney disease in HIV-infected persons in Uganda? If this is premature to characterize, you might reword: In Uganda, the incidence of renal disease in HIV-infected persons is expected to increase, even though highly effective antiretroviral therapy is increasingly available. Indeed we are not seeing higher rates of ESRD or an uptick in clinical presentation of kidney disease in HIV-infected persons in Uganda and we have reworded the sentence (lines 53-54) as the reviewer indicates Methods: 1. It is worth noting that the rate of renal dysfunction would likely have been even higher if you had included persons with hypertension and diabetes in your study population. I think it would be worth mentioning in the abstract that these conditions were excluded. This has been mentioned in the abstract (lines 26-27) as the reviewer indicates 2. Please clarify which anthropometric parameters were assessed. Do you mean BMI? This has been clarified (lines )
4 3. Consider recalculating egfr using the newer Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. It is more accurate than the older MDRD formula, especially in populations (such as HIV infected persons) where muscle mass may be reduced. Use of this newer formula should improve your ability to identify persons who should be screened for renal disease. The equation is given here: Reference: Levey et al. A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) vol. 150 (9) pp We recalculated egfr using CKD-EPI formula as the reviewer indicates and the egfr results now presented in these manuscript are base on CKD-EPI formula 4. It is unclear which variables were included as candidate covariates in the analysis of impaired renal function. I suggest including traditional kidney risk factors (age, gender, glucose, systolic and diastolic blood pressure, lipids, history of cardiovascular disease, BMI, smoking, illicit drug use, proteinuria) and HIV-related factors (Hepatitis C infection status, CD4 cell count, and HIV RNA level), where available. For screening purposes, it could also be useful to learn whether sociodemographic factors are associated with renal function. We did not collect data on glucose, systolic and diastolic blood pressure, lipids, history of cardiovascular disease, illicit drug use but patients who had been previous diagnosed with these conditions were excluded from the study. We also did not collect data on Hepatitis C infection status and HIV RNA level. Traditional kidney risk factors such as age, gender, BMI, smoking, alcohol consumption, proteinuria, serum urea and HIV-related factors, CD4 cell count were the covariates used in the analysis of impaired renal function. Socio-demographic factors, as the reviewer indicates, were analyzed for their association with renal function and only age was significant (tables 1 and 3). 5. Consider adding egfr<60 as a more stringent definition of impaired renal function for consistency with other definitions of CKD, including those you cite (Wyatt et al; Ekat et al). It would be of interest to report both egfr<60 and egfr<90. We have added egfr<60 as a more stringent definition of impaired renal function and reported both egfr<60 and egfr<90 as the reviewer indicates 6. As a secondary analysis, consider using multivariable linear regression to evaluate predictors of egfr as a continuous outcome. This will give you more power to identify associated factors and will enable you to quantify the degree of impairment associated with low CD4 cell count and other factors. Results: 1. The second paragraph of the results section states which statistical tests were used. This information could be moved to the methods section.
5 2. Table 2 states that median and IQR are tabulated, but I don t think this is correct. For age, the result is given as 30 (18-61). If 18 is the lower quartile, this means that 25% of the population was below age 18, which means that children were included. But the title and methods say that only adults were included. Likewise, I don t think the lower quartile for CD4 count was 6. Actually our IQR were not correct as the reviewer indicates. We had used minimum and maximum values. We have reanalyzed and corrected (table 3). For example now median age (IQR) is 30 ( ) years. 3. The last paragraph of the results section states that decreasing CD4 count and increasing age were associated with impaired renal function. Please indicate how these were modelled. The odds ratio for age is 0.69, which would suggest that the odds of impaired renal function drop by 31% with each increment of higher age. That cannot be correct. We have reanalyzed using the variables as continuous variables and the results are now in table 4. The odds ratio (95% confidence interval, P valve) for age and CD4 cell count are ( , 0.005), ( , <0.001) respectively. Discussion: 1. Paragraph 1 of discussion states that Wyatt et al found a prevalence of only 2.7%. A couple of points should be noted: (1) this was a population of HIV+ women; (2) they defined impaired renal function as <60 whereas you are defining it as <90; (3) their median egfr of 90 is the same as yours. Ekat et al also used egfr<60 to define impaired renal function. Their prevalence was 7.9%. I would insert that finding into your discussion. We have included these statements in paragraph 2 of our discussion: Wyatt et al and Ekat et al both used egfr<60ml/min/1.73m 2 to define renal impairment like us and their median egfr of 90 was the same as ours of However, Wyatt et al study involved a population of only HIV positive women while our study included both men and women. 2. I think your conclusions could be strengthened if you could give a more specific recommendation of which categories of patients should be screened for renal disease. A fuller multivariable analysis would inform this recommendation. Indeed our recommendation has been strengthened. Minor points: 1. Table 1: consider reordering the education categories from low to high, starting with no education. 2. Table 2: It is unclear why the N is only 15 (according to the table header). Corrected now N= Table 3: the sign is reversed for low CD4 (should be < not >)
6 4. Table 4: please add the units or categories used to model CD4 count and age. For example, if you defined low CD4 count as <350, then you would label it in this table as CD4 count < 350., CD4 count (cells/μl) and age (years) Level of interest: An article of importance in its field Quality of written English: Acceptable Statistical review: No, the manuscript does not need to be seen by a statistician. Declaration of competing interests: I received an honorarium from Merck for participating in a Renal Expert Input Forum; this honorarium was donated to NCIRE to support kidney research.
7 Reviewer's report Title:Impaired Renal Function and its Predictors among Newly Diagnosed HIV-infected Adults in Gulu Regional Referral Hospital, Northern Uganda Version:2 Date:12 November 2014 Reviewer:MASIMANGO IMANI MANNIX Reviewer's report: Reviewer: Masimango Mannix Major compulsory revisions 1. Title - We propose this title : «Impaired renal function and associated risk factors in newly HIV-infected Adults in Gulu Hospital, Northen Uganda In fact, it is a cross-sectional study; you cannot say "predictors" as in a longitudinal study. We proposed associated risk factors. Some words are removed in the title without changing message. The title of the article has been changed as the reviewer indicates. 2. Abstract - Page 21-28: background: the paragraph it is too long. We suggest this: Screening for renal diseases should be performed at the time of diagnosis of human immunodeficiency virus (HIV) infection. Despite the high prevalence of HIV/AIDS in Northern Uganda, little is known about the status of renal function and its correlates in the newly HIV-infected individuals in this resource limited region. The background has been changed as the reviewer indicates - page 29-34: Methods This paragraph is also long, try to summarize it. In methods section (see page 93), details are available. we suggest this: We conducted a cross-sectional study among newly diagnosed HIV-infected adults. Estimated glomerular filtration rate (egfr) was calculated using MDRD formula. Factors associated with renal dysfunction (egfr< 90 ml/min/1.73m2 and/or proteinuria on dipstick) was thus sought. Summarized as the reviewer suggested, page 25-29: This was a seven month cross-sectional hospital-based study, involving newly diagnosed HIV-infected patients, 18 years and older. Patients with history of diabetes mellitus, hypertension and renal disease were excluded. Estimated glomerular filtration rate (egfr) was calculated using Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. Factors associated with impaired renal function (egfr< 60 ml/min/1.73m 2 ) were thus sought. - Results (page 35-43): relevant results are presented in this section. We suggest: We enrolled 361 participants (230, 63.7% female) with median (IQR) age of 30 (18-61) years. 126, (34.9%) had impaired renal function with 77 (61.1%) having mild renal impairment (egfr mL/min/1.73m2), 34 (27%) moderate impairment (egfr 30-
8 59.9mL/min/1.73m2) while 15 (11.9%) had severe impairment (egfr <30mL/min/1.73m2). Proteinuria was recorded in 189 (52.4%) participants 154 (42.7%) having mild (1+) and while 8 (2.2%) had severe (3+) proteinuria. Indeed have presented relavant results as the reviewer indicates and now we have the results as follows; page 30-34: We enrolled 361 participants (230, 63.7% female) with median (IQR) age of 30 ( ) years. 52, (14.4%) had impaired renal function (egfr <60mL/min/1.73m 2 ) and of this 37 (71.2%) moderate renal impairment (egfr mL/min/1.73m 2 ) while 15 (28.8%) had severe renal impairment (egfr <30mL/min/1.73m 2 ). Proteinuria was recorded in 189 (52.4%) participants. Of these, 154 (81.5%) had mild (1+) while 8 (4.2%) had severe (3+) proteinuria. Page 41-42: remove this phrase: there was a significant.. Page 42: replace at with in 3. Methods section - page : 5 ml was sufficient for all blood tests? Complete blood count needs a tube with anticoagulant and biochemistry tests don t need it. Yes 5 ml was sufficient for all blood tests; we did not do complete blood count. Page mL of venous blood was drawn from each participant into a syringe for renal function tests, and CD4 count. About 1.5mL of blood for CD4 count was transferred into purple top vacutainers and blood for renal function tests was transferred into orange top vacutainers with a gel separator - Page 124: why using the cut-off < 90 ml/min/1.73m 2. According to KDIGO guidelines, in the absence of evidence of kidney damage, neither GFR category G1 (GFR >90) and nor G2 (GFR ml/min/1.73) fulfill the criteria for CKD. The reviewer is correct and we have used the cut-off of egfr< 60 ml/min/1.73m 2 to define renal impairment - how many patients with diabetes or hypertension were excluded? Page : a total of 24 patients were excluded from this study (5 were hypertensive, 4 had diabetes mellitus type II, 6 had pyrexia (>38⁰C), 8 were pregnant and 1 had renal disease. - page 109: know CKD prior to study? How have you excluded it? Yes all patients with known CKD were excluded from our study 4. Results - page Some discussion is made in this part. Eg: this indicates that very big percentages of adults. I suggest this phrase be removed on this section.
9 - Is it possible to have a double entry table with (GFR<90) and without (GFR >90) renal dysfunction and compare different characteristics (socio-demographic, clinical, biological). You mentioned this on page 151 without a table in presentation of results. According to me, if the data are presented in this way, the article will answer the research question: factors associated with renal impairment We reanalyzed the data using GFR <60 ml/min/1.73 m 2 and GFR 60 ml/min/1.73 m 2 to determine patients with and without renal impaired function respectively (table 2) Table 1 has been used to address issue raised by the reviewer about on page 151 without a table in presentation of results and indeed we were able to identify the factors associated with renal impairment - I would suggest that data on blood pressure, blood glucose appear in the results. We did not collect data on blood pressure and blood glucose 5. Discussion - This section will depend on way the results will be presented as suggest above. Level of interest: An article of importance in its field Quality of written English: Acceptable Statistical review: No, the manuscript does not need to be seen by a statistician.
ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)
1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage
More informationDialysis Initiation and Optimal Vascular Access: Outcomes and Mortality
Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage
More informationChapter 2: Identification and Care of Patients With CKD
Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,
More informationAGING KIDNEY IN HIV DISEASE
AGING KIDNEY IN HIV DISEASE Michael G. Shlipak, MD, MPH Professor of Medicine, Epidemiology and Biostatistics, UCSF Chief, General Internal Medicine, San Francisco VA Medical Center Kidney, Aging and HIV
More informationQUICK REFERENCE FOR HEALTHCARE PROVIDERS
KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease
More informationImpaired renal function and associated risk factors in newly diagnosed HIV-infected adults in Gulu Hospital, Northern Uganda
Odongo et al. BMC Nephrology (2015) 16:43 DOI 10.1186/s12882-015-0035-3 RESEARCH ARTICLE Open Access Impaired renal function and associated risk factors in newly diagnosed HIV-infected adults in Gulu Hospital,
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationUpdate on HIV-Related Kidney Diseases. Agenda
Update on HIV-Related Kidney Diseases ANDY CHOI THE MEDICAL MANAGEMENT OF HIV/AIDS DECEMBER 15, 2006 Agenda 1. EPIDEMIOLOGY: A) END STAGE RENAL DISEASE (ESRD) B) CHRONIC KIDNEY DISEASE (CKD) 2. HIV-ASSOCIATED
More informationChronic Kidney Disease: Optimal and Coordinated Management
Chronic Kidney Disease: Optimal and Coordinated Management Michael Copland, MD, FRCPC Presented at University of British Columbia s 42nd Annual Post Graduate Review in Family Medicine Conference, Vancouver,
More informationChapter 2: Identification and Care of Patients With CKD
Chapter 2: Identification and Care of Patients With CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease
More informationA Study on Estimated Glomerular Filtration Rate As A Predictor of Renal Dysfunction Among Adult Hiv Patients on Highly Active Antiretroviral Therapy
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 10 Ver. IX (Oct. 2017), PP 28-34 www.iosrjournals.org A Study on Estimated Glomerular Filtration
More informationSupplementary Online Content
Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.
Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationDisclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationTitle: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy
Author's response to reviews Title: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy Authors: Nan Zhen Dong (dongzn@301hospital.com.cn) Yong
More informationNarender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
More informationDisclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationTitle:Postpartum contraceptive use in Gondar town, Northwest Ethiopia: a community based cross-sectional study
Author's response to reviews Title:Postpartum contraceptive use in Gondar town, Northwest Ethiopia: a community based cross-sectional study Authors: Yeshewas Abera (yeshiab57@gmail.com) Zelalem Birhanu
More informationChapter 2: Identification and Care of Patients with CKD
Chapter 2: Identification and Care of Patients with CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease
More informationConcept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA
Concept and General Objectives of the Conference: Prognosis Matters Andrew S. Levey, MD Tufts Medical Center Boston, MA General Objectives Topics to discuss What are the key outcomes of CKD? What progress
More informationThe relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan
Environ Health Prev Med (2011) 16:191 195 DOI 10.1007/s12199-010-0183-9 SHORT COMMUNICATION The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan Nobuyuki
More informationChapter Two Renal function measures in the adolescent NHANES population
0 Chapter Two Renal function measures in the adolescent NHANES population In youth acquire that which may restore the damage of old age; and if you are mindful that old age has wisdom for its food, you
More informationOutline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationSpecial Challenges and Co-Morbidities
Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine
More informationComposite Performance Report
Composite Performance Report 10 9 91% 8 7 65% 68% 65% 6 56% 5 4 3 2 44% 37% 48% 31% 19% 29% 1 6% Key: Report Measure Name Cohort Target Cohort Definition Formula 1 Control Blood Pressure All patients who
More informationPrevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study
International Journal of Advances in Medicine Sathyan S et al. Int J Adv Med. 2017 Feb;4(1):247-251 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170120
More informationKey Words: Screening, egfr, Newly Diagnosed Hypertensives, Diabetics
EGFR AND CHRONIC KIDNEY DISEASE STAGES AMONG NEWLY DIAGNOSED ASYMPTOMATIC HYPERTENSIVES AND DIABETICS SEEN IN A TERTIARY HEALTH CENTER IN NIGERIA Objectives: Moderate to severe CKD, may be symptomless
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease
More informationA New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta
A New Approach for Evaluating Renal Function and Predicting Risk William McClellan, MD, MPH Emory University Atlanta Goals Understand the limitations and uses of creatinine based measures of kidney function
More informationPrimary Care Approach to Management of CKD
Primary Care Approach to Management of CKD This PowerPoint was developed through a collaboration between the National Kidney Foundation and ASCP. Copyright 2018 National Kidney Foundation and ASCP Low
More informationCHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH SCIENTIFIC DIRECTOR KIDNEY HEALTH RESEARCH COLLABORATIVE - UCSF CHIEF - GENERAL INTERNAL MEDICINE, SAN FRANCISCO
More informationPredicting and changing the future for people with CKD
Predicting and changing the future for people with CKD I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University
More informationRationale: Objectives: Indication: Diabetes Mellitus, Type 2 Study Investigators/Centers: 300 physicians in 292 clinics Research Methods: Data Source:
GSK Medicine: N/A Study No.: 112255 Title: A Korean, multi-center, nation-wide, cross-sectional, epidemiology study to identify prevalence of diabetic nephropathy in hypertensive patients with type 2 diabetes
More informationCHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationElevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC
Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007
More informationReviewer s report. Version: 0 Date: 17 Dec Reviewer: Julia Marcus. Reviewer's report:
Reviewer s report Title: Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with human immunodeficiency virus (HIV)?: a cohort collaboration
More informationChapter 1: CKD in the General Population
Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table
More informationTitle: Defensive coping and health-related quality of life in Chronic Kidney Disease: a cross-sectional study
Author's response to reviews Title: Defensive coping and health-related quality of life in Chronic Kidney Disease: a cross-sectional study Authors: Anna Kaltsouda (akalts@cc.uoi.gr) Petros Skapinakis (p.skapinakis@gmail.com)
More informationE.Ritz Heidelberg (Germany)
Predictive capacity of renal function in cardiovascular disease E.Ritz Heidelberg (Germany) If a cure is not achieved, the kidneys will pass on the disease to the heart Huang Ti Nei Ching Su Wen The Yellow
More informationTitle: Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting
Author's response to reviews Title: Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting Authors: Micaela Brandolini (m.brandolini@smatteo.pv.it)
More informationTitle:Risk Factors and Their Interaction on Chronic Kidney Disease: A Multi-Center Case-Control Study in Taiwan
Author's response to reviews Title:Risk Factors and Their Interaction on Chronic Kidney Disease: A Multi-Center Case-Control Study in Taiwan Authors: Sui-Lung Su (a131419@gmail.com) Chin Lin (xup6fup@hotmail.com)
More informationTHE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS
214 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 21(3):23-212 doi: 1.2478/rjdnmd-214-25 THE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES
More informationCKDinform: A PCP s Guide to CKD Detection and Delaying Progression
CKDinform: A PCP s Guide to CKD Detection and Delaying Progression Learning Objectives Describe suitable screening tools, such as GFR and ACR, for proper utilization in clinical practice related to the
More informationProfessor Suetonia Palmer
Professor Suetonia Palmer Department of Medicine Nephrologist Christchurch Hospital Christchurch 14:00-14:55 WS #108: The Kidney Test - When To Test and When to Refer ( and When Not To) 15:05-16:00 WS
More informationBASELINE CHARACTERISTICS OF THE STUDY POPULATION
Study Summary DAILY ORAL SODIUM BICARBONATE PRESERVES GLOMERULAR FILTRATION RATE BY SLOWING ITS DECLINE IN EARLY HYPERTENSIVE NEPHROPATHY This was a 5-year, single-center, prospective, randomized, placebo-controlled,
More informationOptimal blood pressure targets in chronic kidney disease
Optimal blood pressure targets in chronic kidney disease Pr. Michel Burnier Service of Nephrology and Hypertension University Hospital Lausanne Switzerland Evidence-Based Guideline for the Management
More informationDifferences in Calculated Glomerular Filtration Rates (GFR) in Efavirenz (EFV) or Tenofovir (TDF)-treated Adults in ESS40006
13th Conference on Retroviruses and Opportunistic Infections Denver, CO, USA. February 5-9, 2006 Poster Number 777 Differences in Calculated Glomerular Filtration Rates (GFR) in Efavirenz (EFV) or Tenofovir
More informationOffice Management of Reduced GFR Practical advice for the management of CKD
Office Management of Reduced GFR Practical advice for the management of CKD CKD Online Education CME for Primary Care April 27, 2016 Monica Beaulieu, MD FRCPC MHA CHAIR PROVINCIAL KIDNEY CARE COMMITTEE
More informationAuthor's response to reviews
Author's response to reviews Title:The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of
More informationRisk for chronic kidney disease increases with obesity: Health Survey for England 2010
Public Health Nutrition: 18(18), 3349 3354 doi:10.1017/s1368980015000488 Risk for chronic kidney disease increases with obesity: Health Survey for England 2010 Helen L MacLaughlin 1,2, *, Wendy L Hall
More informationTitle:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients
Author's response to reviews Title:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients Authors: Da Shang (sdshangda@163.com) Qionghong
More informationAuthor's response to reviews
Author's response to reviews Title:How differently do physicians and patients evaluate the current status of primary care in Korea?: A qualitative study using focus group discussion Authors: Minsu Ock
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More informationegfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
More informationNice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care
Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care Paula D Souza Senior CKD Nurse Specialist Royal Devon and Exeter Healthcare Trust Introduction Background What
More informationEvaluation of Chronic Kidney Disease KDIGO. Paul E de Jong University Medical Center Groningen The Netherlands
Evaluation of Chronic Kidney Disease Paul E de Jong University Medical Center Groningen The Netherlands Evaluation and Management of CKD 1. Definition and classification of CKD 2. Definition and impact
More informationFaculty/Presenter Disclosure
CSI for CKD Unravelling the myths surrounding chronic kidney disease Practical Evidence for Informed Practice Oct 21 2016 Dr. Scott Klarenbach University of Alberta Slide 1: Option B (Presenter with NO
More informationEFFECTS OF ATORVASTATIN AND ROSUVASTATIN ON RENAL FUNCTION IN PATIENTS AT HIGH CARDIOVASCULAR RISK: A META-ANALYSIS OF 23 RANDOMIZED TRIALS
EFFECTS OF ATORVASTATIN AND ROSUVASTATIN ON RENAL FUNCTION IN PATIENTS AT HIGH CARDIOVASCULAR RISK: A META-ANALYSIS OF 23 RANDOMIZED TRIALS Gianluigi Savarese, MD 1, Massimo Volpe, MD, PhD 2, Francesca
More informationChronic Kidney Disease. Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital
Chronic Kidney Disease Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital Health Seminar Series Date 12 May 2013 Objectives Normal functioning of Kidneys. Risk factors to
More informationPEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Kristine Hommel Department of nephrology, Herlev Hospital, Denmark 17-Nov-2015
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
More informationA STUDY ON DYSLIPIDAEMIA IN CHRONIC KIDNEY DISEASE (CKD) WITH SPECIAL REFERENCE TO HAEMODIALYSIS
A STUDY ON DYSLIPIDAEMIA IN CHRONIC KIDNEY DISEASE (CKD) WITH SPECIAL REFERENCE TO HAEMODIALYSIS Shweta Sharma 1, Sandhya Gautam 2, Dhanveer Singh 3, Prachi Sharma 4, Avriti Baweja 5 1Assistant Professor,
More informationTHE IMPACT OF CCB AND RAS INHIBITOR COMBINATION THERAPY TO PREVENT CKD INCIDENCE IN HYPERTENSION AND ADVANCED ATHEROSCLEROSIS
THE IMPACT OF CCB AND RAS INHIBITOR COMBINATION THERAPY TO PREVENT CKD INCIDENCE IN HYPERTENSION AND ADVANCED ATHEROSCLEROSIS Daisuke MAEBUCHI, Yasuyuki SHIRAISHI, Hiroaki TANAKA, Yumiko INUI, Makoto TAKEI,
More informationChronic Kidney Disease as cardiovascular risk predictor Evidence based clinical management. Fabio Mazza
Chronic Kidney Disease as cardiovascular risk predictor Evidence based clinical management Fabio Mazza CKD (Chronic Kidney Disease) is an ever-increasing clinical condition marked by a progressive reduction
More informationAnalytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health
Analytical Methods: the Kidney Early Evaluation Program (KEEP) 2000 2006 Database Design and Study Participants The Kidney Early Evaluation program (KEEP) is a free, community based health screening program
More informationSerum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting glucose: The Rancho Bernardo Study
Diabetes Care Publish Ahead of Print, published online June 9, 2009 Serum uric acid and incident DM2 Serum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting
More informationThis is the author s version of a work that was submitted/accepted for publication in the following source:
This is the author s version of a work that was submitted/accepted for publication in the following source: Kelly, Mark D., Gibson, Abby, Bartlett, Harry, Rowling, Diane, & Patten, John (2013) Tenofovir-associated
More informationIndividual Study Table Referring to Part of Dossier: Volume: Page:
Synopsis Abbott Laboratories Name of Study Drug: Paricalcitol Capsules (ABT-358) (Zemplar ) Name of Active Ingredient: Paricalcitol Individual Study Table Referring to Part of Dossier: Volume: Page: (For
More informationValidity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children
Validity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children *H W Dilanthi 1, G A M Kularatnam 1, S Jayasena 1, E Jasinge 1, D B D L Samaranayake
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationWhat should you do next? Presenter Disclosure Information. Learning Objectives. Case: George
2:45 3:45pm Optimizing the Management of Patients with Chronic Kidney Disease SPEAKER Jay B. Wish, MD, FACP Presenter Disclosure Information The following relationships exist related to this presentation:
More informationCKD and risk management : NICE guideline
CKD and risk management : NICE guideline 2008-2014 Shahed Ahmed Consultant Nephrologist shahed.ahmed@rlbuht.nhs.uk Key points : Changing parameters of CKD and NICE guidance CKD and age related change of
More informationAcknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD
A Practical Approach to Chronic Kidney Disease Management for the Primary Care Practioner: A web-site sponsored by the National Kidney Foundation of Connecticut Robert Reilly, M.D. Acknowledgements National
More informationIntroduction to Clinical Diagnosis Nephrology
Introduction to Clinical Diagnosis Nephrology I. David Weiner, M.D. C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University of Florida College
More informationZhao Y Y et al. Ann Intern Med 2012;156:
Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled
More informationHHS Public Access Author manuscript Am J Kidney Dis. Author manuscript; available in PMC 2017 July 05.
HHS Public Access Author manuscript Published in final edited form as: Am J Kidney Dis. 2017 March ; 69(3): 482 484. doi:10.1053/j.ajkd.2016.10.021. Performance of the Chronic Kidney Disease Epidemiology
More informationChapter 2: Definition, identification, and prediction of CKD progression Kidney International Supplements (2013) 3, 63 72; doi: /kisup.2012.
http://www.kidney-international.org chapter 2 & 2013 KDIGO Chapter 2: Definition, identification, and prediction of CKD progression Kidney International Supplements (2013) 3, 63 72; doi:10.1038/kisup.2012.65
More informationP.K. Tandon, PhD J. Alexander Cole, DSc. Use of Registries for Clinical Evaluation of Rare Diseases
Disclaimer: Presentation slides from the Rare Disease Workshop Series are posted by the Kakkis EveryLife Foundation, for educational purposes only. They are for use by drug development professionals and
More informationSummary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup
http://www.kidney-international.org & 2013 DIGO Summary of Recommendation Statements idney International Supplements (2013) 3, 5 14; doi:10.1038/kisup.2012.77 Chapter 1: Definition and classification of
More informationTitle: The role of cognitive stimulation at home in low-income preschoolers' nutrition, physical activity and Body Mass Index
Reviewer s report Title: The role of cognitive stimulation at home in low-income preschoolers' nutrition, physical activity and Body Mass Index Version: 1 Date: 23 Feb 2017 Reviewer: Pattanee Winichagoon
More informationOutline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More informationChronic Renal Failure Followed by Acute Renal Failure
Chronic Renal Failure Followed by Acute Renal Failure Dr Emre Karakoç Çukurova Üniversity Department of Medical ICU Terminology Acute Kidney Injury Chronic Kidney Disease Acute Kidney Disease Acute kidney
More informationTitle:Prevalence of binge drinking and associated behaviours among 3286 college students in France
Author's response to reviews Title:Prevalence of binge drinking and associated behaviours among 3286 college students in France Authors: Marie-Pierre Tavolacci (marie-pierre.tavolacci@chu-rouen.fr) Eloise
More informationChronic renal histological changes at implantation and subsequent deceased donor kidney transplant outcomes: a single-centre analysis
Chronic renal histological changes at implantation and subsequent deceased donor kidney transplant outcomes: a single-centre analysis Benedict Phillips 1, Kerem Atalar 1, Hannah Wilkinson 1, Nicos Kessaris
More informationChapter 2: Identification and Care of Patients With Chronic Kidney Disease
Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets
More informationFrailty Predicts Recurrent but Not Single Falls 10 Years Later in HIV+ and HIV- Women
Frailty Predicts Recurrent but Not Single Falls 10 Years Later in HIV+ and HIV- Women Anjali Sharma, Deborah Gustafson, Donald R Hoover, Qiuhu Shi, Michael W Plankey, Phyllis C Tien, Kathleen Weber, Michael
More informationCreatinine (serum, plasma)
Creatinine (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Creatinine 1.2 Alternative names None 1.3 Description of analyte Creatinine is a heterocyclic nitrogenous compound (IUPAC
More informationMarginal donors: Young vs. Old
Marginal donors: Young vs. Old Why we should prefer older donors Geir Mjøen, Oslo, Norway Long term risks in kidney donors Interpretation Consequences Recommendation Kidney donors Donors are healthy at
More informationThe Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
More informationTitle: Prognostic factors for non-success in patients with sciatica and disc herniation
Author's response to reviews Title: Prognostic factors for non-success in patients with sciatica and disc herniation Authors: Anne J Haugen (annhau@so-hf.no) Jens I Brox (j.i.brox@medisin.uio.no) Lars
More informationAssessing Renal Function: What you Didn t Know You Didn t Know
Assessing Renal Function: What you Didn t Know You Didn t Know Presented By Tom Wadsworth PharmD, BCPS Associate Clinical Professor UAA/ISU Doctor of Pharmacy Program Idaho State University College of
More informationManagement of early chronic kidney disease
Management of early chronic kidney disease GREENLANE SUMMER GP SYMPOSIUM 2018 Jonathan Hsiao Renal and General Physician Introduction A growing public health problem in NZ and throughout the world. Unknown
More informationDonation from Old Living Donors How safe is it? Safe for recipient or donor?
Donation from Old Living Donors How safe is it? Safe for recipient or donor? Pr Lionel Rostaing Service de Néphrologie, Hémodialyse, Aphérèses et Transplantation CHU Grenoble Alpes France lrostaing@chu-grenoble.fr
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response
More informationKidney Disease in HIV. Kidney Disease in HIV: An Update for Ryan White Providers
Kidney Disease in HIV: An Update for Ryan White Providers Christina M. Wyatt, MD Assistant Professor Mount Sinai School of Medicine New York, New York FORMATTED: 11/16/2015 Learning Objectives After attending
More informationTitle:Modern contraceptive use among sexually active men in Uganda: Does discussion with a health worker matter?
Author's response to reviews Title:Modern contraceptive use among sexually active men in Uganda: Does discussion with a health worker matter? Authors: Allen Kabagenyi Ms. (allenka79@yahoo.com) Patricia
More informationTitle: Socioeconomic conditions and number of pain sites in women
Author's response to reviews Title: Socioeconomic conditions and number of pain sites in women Authors: Finn E Skjeldestad (fisk@fhi.no) Toril Rannestad (Toril.Rannestad@hist.no) Version: 2 Date: 17 January
More informationKEEP 2.0 Annual Data Report Chapter Five
KEEP 2. Annual Data Report Chapter Five Figure 5.1 percent distribution of KEEP participants with elevated serum creatinine levels, overall & by age 16 Percent of participants 12 8 4 All
More information